rotate-mobile
Giovedì, 25 Aprile 2024
Salute

Abcam Announces Successful Acquisition of Expedeon's Proteomics and Immunology Business, Enhancing Its Conjugation Capability



In Evidenza

Potrebbe interessarti

Abcam Announces Successful Acquisition of Expedeon's Proteomics and Immunology Business, Enhancing Its Conjugation Capability

Today è in caricamento